Angiogenesis


During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
A4187 FG-4592 (ASP1517)5 CitationSummary: HIF prolyl-hydroxylase inhibitor -
A4188 2-Methoxyestradiol (2-MeOE2)2 CitationSummary: Apoptotic, antiproliferative and antiangiogenic agent -
A4189 IOX2(Glycine)1 CitationSummary: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor -
A4507 KC7F25 CitationSummary: HIF-1α inhibitor -
A4509 PX 121 CitationTarget: TrxSummary: Trx-1 inhibitor -
A4506 DMOG4 CitationTarget: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)Summary: Competitive HIF-PH inhibitor, cell-permeable -
A8229 ML161Target: Protease-Activated ReceptorsSummary: PAR1 inhibitor -
A8233 DMXAA (Vadimezan)2 CitationTarget: DT-diaphorasesSummary: Tumnor vascular disrupting agent, apoptosis inducer -
A8636 RN486Summary: Btk inhibitor,potent and selective -
A8660 Cilengitide1 CitationTarget: IntegrinsSummary: Integrin inhibitor for αvβ3 and αvβ5

